Table 1.

Irradiated donor splenocytes co-infused with bone marrow cells enhance allogeneic bone marrow engraftment

Recipient miceFVB (H-2q) BM cellsFVB (H-2q) irradiated SCsMice engrafted
(H-2q phenotype) at day
45 to day 50 post-BMT (%)*
C57BL/6 (H-2b3 × 105 None 3 (1/28)  
 3 × 105 5 × 106 57 (15/26) 
BALB/c (H-2d3 × 105 None 2 (1/44)  
 3 × 105 5 × 106 38 (17/44) 
BALB/c (H-2d106 None 11 (5/44) 
 106 5 × 106 49 (25/51) 
Recipient miceFVB (H-2q) BM cellsFVB (H-2q) irradiated SCsMice engrafted
(H-2q phenotype) at day
45 to day 50 post-BMT (%)*
C57BL/6 (H-2b3 × 105 None 3 (1/28)  
 3 × 105 5 × 106 57 (15/26) 
BALB/c (H-2d3 × 105 None 2 (1/44)  
 3 × 105 5 × 106 38 (17/44) 
BALB/c (H-2d106 None 11 (5/44) 
 106 5 × 106 49 (25/51) 

BM, bone marrow; SCs, splenocytes; BMT, bone marrow transplantation.

*

Pooled results of 3 to 5 independent experiments. Number of engrafted mice/number of analyzed mice at day 45 to day 50 post-BMT are indicated in parentheses.

P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal